[Conversion from +Sandimmune to Neoral in kidney transplant recipients treated with cyclosporine and ketoconazole].

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Revista médica de Chile (Impresa)

• Publication date

  1997-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 9460285
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year.

  1996cited by this paper
• Pharmacokinetic profile of cyclosporine A after conversion to Sandimmun Optoral: influence on ambulatory blood pressure in renal transplant patients.

  1996cited by this paper
• CYCLOSPORINE (SANDIMMUN®) IN CADAVERIC RENAL TRANSPLANTATION TEN‐YEAR FOLLOW‐UP OF A MULTICENTER TRIAL

  1995cited by this paper
• A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function.

  1995cited by this paper
• Neoral--a new microemulsion formula of cyclosporine A: interpatient pharmacokinetic variability in renal transplant recipients.

  1995cited by this paper
• Elective cyclosporine withdrawal 1 year after renal transplantation.

  1994cited by this paper
• Long-term efficacy and safety of cyclosporine in renal-transplant recipients.

  1994cited by this paper
• Acute effects of nifedipine in renal transplant recipients treated with cyclosporine or azathioprine.

  1994cited by this paper
• The Neoral formulation: improved correlation between cyclosporine trough levels and exposure in stable renal transplant recipients.

  1994cited by this paper
• Optimization and long-term evaluation of renal function in sandimmune-treated renal allograft recipients.

  1993cited by this paper
• DILTIAZEM IN RENAL ALLOGRAFT RECIPIENTS RECEIVING CYCLOSPORINE

  1993cited by this paper
• CYCLOSPORINE‐KETOCONAZOLE INTERACTION: LONG‐TERM FOLLOW‐UP AND PRELIMINARY RESULTS OF A RANDOMIZED TRIAL

  1993cited by this paper
• Long-term graft survival after conversion from cyclosporin to azathioprine 1 year after renal transplantation. A prospective, randomized study from 1 to 6 years after transplantation.

  1993cited by this paper
• EXCELLENT OUTCOME WITH A CALCIUM CHANNEL BLOCKER—SUPPLEMENTED IMMUNOSUPPRESSIVE REGIMEN IN CADAVERIC RENAL TRANSPLANTATION: A POTENTIAL STRATEGY TO AVOID ANTIBODY INDUCTION PROTOCOLS

  1993cited by this paper
• Renal transplantation in the cyclosporine era.

  1993cited by this paper
• Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants.

  1993cited by this paper
• Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion.

  1993cited by this paper
• The utility of cyclosporine weaning in renal transplantation.

  1992cited by this paper
• Concomitant administration of cyclosporine and ketoconazole in renal transplant patients.

  1992cited by this paper
• RENAL TRANSPLANT FUNCTION AFTER TEN YEARS OF CYCLOSPORINE

  1992cited by this paper
• Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients.

  1991cited by this paper
• Mechanism of cyclosporine-induced hypertension.

  1991cited by this paper
• Long-term, low-dose cyclosporine treatment of renal allograft recipients. A randomized trial.

  1990cited by this paper
• Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects.

  1989cited by this paper
• Inhibition of cyclosporine metabolism by other drugs in vitro.

  1988cited by this paper
• Five-year serial renal graft biopsy study in cyclosporine-treated patients.

  1988cited by this paper
• Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in blood.

  1988cited by this paper
• Controlled cyclosporine conversion at three months after renal transplantation. Long-term results.

  1988cited by this paper
• Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function.

  1987cited by this paper
• Cyclosporine-associated chronic nephropathy.

  1984cited by this paper
• Cyclosporine and ketoconazole.

  1984cited by this paper
• A randomized clinical trial of cyclosporine in cadaveric renal transplantation.

  1983cited by this paper
• Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.

  1979cited by this paper

• Combining cytochrome P-450 3A4 modulators and cyclosporine or everolimus in transplantation is successful.

  2015cites this paper
• Hepatotoxicity associated with cyclosporine monitoring using C2 recommendations in adults renal recipients receiving ketoconazole.

  2005cites this paper
• Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of Neoral and diltiazem or ketoconazol in stable adult kidney transplants.

  1998cites this paper